These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22664066)

  • 1. Optimal but unequitable prophylactic distribution of vaccine.
    Keeling MJ; Shattock A
    Epidemics; 2012 Jun; 4(2):78-85. PubMed ID: 22664066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of vaccination strategies for SIR epidemics on random networks incorporating household structure.
    Ball F; Sirl D
    J Math Biol; 2018 Jan; 76(1-2):483-530. PubMed ID: 28634747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal control of vaccination dynamics during an influenza epidemic.
    Jaberi-Douraki M; Moghadas SM
    Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control.
    Coltart CE; Johnson AM; Whitty CJ
    BMC Med; 2015 Oct; 13():271. PubMed ID: 26482396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptotic Analysis of Optimal Vaccination Policies.
    Penn MJ; Donnelly CA
    Bull Math Biol; 2023 Jan; 85(3):15. PubMed ID: 36662446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimised prophylactic vaccination in metapopulations.
    Teo M; Bean N; Ross JV
    Epidemics; 2021 Mar; 34():100420. PubMed ID: 33360869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing vaccine allocation at different points in time during an epidemic.
    Matrajt L; Longini IM
    PLoS One; 2010 Nov; 5(11):e13767. PubMed ID: 21085686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
    Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
    BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.
    Miura F; Leung KY; Klinkenberg D; Ainslie KEC; Wallinga J
    PLoS Comput Biol; 2021 Dec; 17(12):e1009697. PubMed ID: 34898617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal vaccination in a stochastic epidemic model of two non-interacting populations.
    Yuan EC; Alderson DL; Stromberg S; Carlson JM
    PLoS One; 2015; 10(2):e0115826. PubMed ID: 25688857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal control of epidemics with limited resources.
    Hansen E; Day T
    J Math Biol; 2011 Mar; 62(3):423-51. PubMed ID: 20407775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal vaccine allocation during the mumps outbreak in two SIR centres.
    Chernov AA; Kelbert MY; Shemendyuk AA
    Math Med Biol; 2020 Sep; 37(3):303-312. PubMed ID: 31271214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal prophylactic vaccination in segregated populations: When can we improve on the equalising strategy?
    Keeling MJ; Ross JV
    Epidemics; 2015 Jun; 11():7-13. PubMed ID: 25979277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal vaccine allocation for the control of sexually transmitted infections.
    Saldaña F; Steindorf V; Srivastav AK; Stollenwerk N; Aguiar M
    J Math Biol; 2023 Apr; 86(5):75. PubMed ID: 37058156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of childrens' vaccination for COVID-19-Pareto-optimal allocations of vaccines.
    Gavish N; Katriel G
    PLoS Comput Biol; 2022 Feb; 18(2):e1009872. PubMed ID: 35213541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allocating epidemic response teams and vaccine deliveries by drone in generic network structures, according to expected prevented exposures.
    Matter D; Potgieter L
    PLoS One; 2021; 16(3):e0248053. PubMed ID: 33667263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemic prevalence information on social networks can mediate emergent collective outcomes in voluntary vaccine schemes.
    Sharma A; Menon SN; Sasidevan V; Sinha S
    PLoS Comput Biol; 2019 May; 15(5):e1006977. PubMed ID: 31120877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive vaccination in the presence of disease hotspots.
    Azman AS; Lessler J
    Proc Biol Sci; 2015 Jan; 282(1798):20141341. PubMed ID: 25392464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projecting vaccine demand and impact for emerging zoonotic pathogens.
    Lerch A; Ten Bosch QA; L'Azou Jackson M; Bettis AA; Bernuzzi M; Murphy GAV; Tran QM; Huber JH; Siraj AS; Bron GM; Elliott M; Hartlage CS; Koh S; Strimbu K; Walters M; Perkins TA; Moore SM
    BMC Med; 2022 Jun; 20(1):202. PubMed ID: 35705986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal vaccination strategies for COVID-19 in population migration between two regions scenario.
    Zuo C; Ling Y; Guo Y; Zhang M; Meng Z; Xiang G
    Hum Vaccin Immunother; 2023 Aug; 19(2):2223108. PubMed ID: 37350470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.